Abbott Laboratories said the U.S. Food and Drug Administration approved its Proclaim XR medical device to treat chronic pain.
The Abbott Park, Ill.-based medical-device maker's product helps change pain signals as they travel from the spine to the brain and was found to be effective in 24 patients enrolled in a study called Bold.
There are an estimated 50 million people in the U.S. who are affected by chronic pain, which hinders one's ability to move around and work.
